Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180

Blood pressure in hemodialysis patients is difficult to control. The adequate use of antihypertensive drugs, associated with a good control of blood volume, are the most appropriate measures for the control of blood pressure in these patients. to objective describe the main drug classes used to cont...

Descripción completa

Detalles Bibliográficos
Autores: Vilella Hartwig, Shaiana, Lescano de Sousa Junior, Alcione, Ignotti, Eliane
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:Brasil
Institución:Centro Universitário São Camilo
Repositorio:O Mundo da Saúde (Online)
Idioma:portugués
OAI Identifier:oai:ojs3.revistamundodasaude.emnuvens.com.br:article/147
Acceso en línea:https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147
Access Level:acceso abierto
Palabra clave:Hipertensão. Diálise renal. Perfil de saúde.
Hypertension, Kidney dialysis, Health profile.
id BR_fb0e1ea80e4ac8a05ddda1817ed22c8e
oai_identifier_str oai:ojs3.revistamundodasaude.emnuvens.com.br:article/147
network_acronym_str BR
network_name_str Brasil
repository_id_str
dc.title.none.fl_str_mv Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
Medicamentos para hipertensão de pacientes em hemodiálise em Cáceres - Mato Grosso, Brasil: DOI: 10.15343/0104-7809.20184201158180
title Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
spellingShingle Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
Vilella Hartwig, Shaiana
Hipertensão. Diálise renal. Perfil de saúde.
Hypertension, Kidney dialysis, Health profile.
title_short Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
title_full Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
title_fullStr Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
title_full_unstemmed Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
title_sort Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180
dc.creator.none.fl_str_mv Vilella Hartwig, Shaiana
Lescano de Sousa Junior, Alcione
Ignotti, Eliane
author Vilella Hartwig, Shaiana
author_facet Vilella Hartwig, Shaiana
Lescano de Sousa Junior, Alcione
Ignotti, Eliane
author_role author
author2 Lescano de Sousa Junior, Alcione
Ignotti, Eliane
author2_role author
author
dc.subject.por.fl_str_mv Hipertensão. Diálise renal. Perfil de saúde.
Hypertension, Kidney dialysis, Health profile.
topic Hipertensão. Diálise renal. Perfil de saúde.
Hypertension, Kidney dialysis, Health profile.
description Blood pressure in hemodialysis patients is difficult to control. The adequate use of antihypertensive drugs, associated with a good control of blood volume, are the most appropriate measures for the control of blood pressure in these patients. to objective describe the main drug classes used to control hypertension and to describe the epidemiological profile of chronic kidney disease patients on hemodialysis in the city of Cáceres-MT in the year 2014. Descriptive, cross-sectional epidemiological study with patients underwent hemodialysis in 2014 in the city of Cáceres, by means of patient medical records of a total of 17,134 hemodialysis sessions with 133 patients. The majority were male, black, married, with a mean age of 55 years, with hypertensive nephrosclerosis as the underlying disease. The main comorbidity was diabetes mellitus; 80% are diagnosed of end-stage chronic kidney disease; the mean time on hemodialysis (survival) was 4.8 years and 78.6% were hypertensive. Among hypertensive patients, 41.8% used a combination of two antihypertensive drugs and 32.6% used monotherapy; the adrenergic inhibitors class used was 27.1%, and 12.5% received diuretics. There was a mean survival of 5.2 years for hypertensive patients. The drug therapy used to control blood pressure complies with international recommendations in 81.6% of cases. The characteristics of patients being treated are similar to the other cities in the country. The mean survival of the hypertensive group of patients was higher than that of the non-hypertensive group.
publishDate 2018
dc.date.none.fl_str_mv 2018-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147
url https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147/121
dc.rights.driver.fl_str_mv Copyright (c) 2018 CC BY
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 CC BY
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Centro Universitário São Camilo
publisher.none.fl_str_mv Centro Universitário São Camilo
dc.source.none.fl_str_mv O Mundo da Saúde; Vol. 42 No. 1 (2018): JANUARY/MARCH 2018; 158-180
O Mundo da Saúde; Vol. 42 Núm. 1 (2018): JANUARY/MARCH 2018; 158-180
O Mundo da Saúde; v. 42 n. 1 (2018): JANEIRO/MARÇO DE 2018 ; 158-180
1980-3990
0104-7809
reponame:O Mundo da Saúde (Online)
instname:Centro Universitário São Camilo
instacron:SAOCAMILO
instname_str Centro Universitário São Camilo
instacron_str SAOCAMILO
institution SAOCAMILO
reponame_str O Mundo da Saúde (Online)
collection O Mundo da Saúde (Online)
repository.name.fl_str_mv O Mundo da Saúde (Online) - Centro Universitário São Camilo
repository.mail.fl_str_mv mundodasaude@saocamilo-sp.br || secretariapublica@saocamilo-sp.br
_version_ 1853663486460035072
spelling Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180Medicamentos para hipertensão de pacientes em hemodiálise em Cáceres - Mato Grosso, Brasil: DOI: 10.15343/0104-7809.20184201158180Hipertensão. Diálise renal. Perfil de saúde.Hypertension, Kidney dialysis, Health profile.Blood pressure in hemodialysis patients is difficult to control. The adequate use of antihypertensive drugs, associated with a good control of blood volume, are the most appropriate measures for the control of blood pressure in these patients. to objective describe the main drug classes used to control hypertension and to describe the epidemiological profile of chronic kidney disease patients on hemodialysis in the city of Cáceres-MT in the year 2014. Descriptive, cross-sectional epidemiological study with patients underwent hemodialysis in 2014 in the city of Cáceres, by means of patient medical records of a total of 17,134 hemodialysis sessions with 133 patients. The majority were male, black, married, with a mean age of 55 years, with hypertensive nephrosclerosis as the underlying disease. The main comorbidity was diabetes mellitus; 80% are diagnosed of end-stage chronic kidney disease; the mean time on hemodialysis (survival) was 4.8 years and 78.6% were hypertensive. Among hypertensive patients, 41.8% used a combination of two antihypertensive drugs and 32.6% used monotherapy; the adrenergic inhibitors class used was 27.1%, and 12.5% received diuretics. There was a mean survival of 5.2 years for hypertensive patients. The drug therapy used to control blood pressure complies with international recommendations in 81.6% of cases. The characteristics of patients being treated are similar to the other cities in the country. The mean survival of the hypertensive group of patients was higher than that of the non-hypertensive group.A pressão arterial em hemodialisados é de difícil controle. O uso adequado de anti-hipertensivos, associado a um bom controle da volemia, constituem-se nas medidas mais apropriadas para o controle da pressão arterial nestes pacientes. O objetivo é descrever as principais classes medicamentosas utilizadas para o controle da hipertensão e descrever o perfil epidemiológico dos pacientes renais crônicos em hemodiálise no município de Cáceres-MT no ano de 2014. Estudo epidemiológico descritivo, transversal, com pacientes em hemodiálise que dialisaram no ano de 2014 no município de Cáceres, por meio dos registros em prontuários de um total de 17.134 sessões de hemodiálise de 133 pacientes. A maioria é do sexo masculino, da raça negra, casados, com média de idade de 55 anos, com nefroesclerose hipertensiva como doença de base. A principal comorbidade é a diabetes mellitus; 80% tem diagnóstico de doença renal crônica em estágio final; a média de tempo em hemodiálise (sobrevida) foi de 4,8 anos e 78,6% são hipertensos. Entre os hipertensos 41,8% utilizam combinação de dois anti-hipertensivos e 32,6% utilizam monoterapia; a classe dos inibidores adrenérgicos foi utilizada em 27,1% e 12,5% receberam diuréticos. Verificou-se média de sobrevida de 5,2 anos para os hipertensos. A terapêutica medicamentosa utilizada para controle da pressão arterial atende as recomendações internacionais em 81,6% dos casos. As características dos pacientes em tratamento são comuns a outras localidades do país. A média de sobrevida do grupo de pacientes hipertensos foi maior que do grupo de não hipertensos.Centro Universitário São Camilo2018-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147O Mundo da Saúde; Vol. 42 No. 1 (2018): JANUARY/MARCH 2018; 158-180O Mundo da Saúde; Vol. 42 Núm. 1 (2018): JANUARY/MARCH 2018; 158-180O Mundo da Saúde; v. 42 n. 1 (2018): JANEIRO/MARÇO DE 2018 ; 158-1801980-39900104-7809reponame:O Mundo da Saúde (Online)instname:Centro Universitário São Camiloinstacron:SAOCAMILOporhttps://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147/121Copyright (c) 2018 CC BYinfo:eu-repo/semantics/openAccessVilella Hartwig, Shaiana Lescano de Sousa Junior, Alcione Ignotti, Eliane 2020-08-14T18:53:03Zoai:ojs3.revistamundodasaude.emnuvens.com.br:article/147Revistahttps://revistamundodasaude.emnuvens.com.br/mundodasaude/indexPRIhttps://revistamundodasaude.emnuvens.com.br/mundodasaude/oamundodasaude@saocamilo-sp.br || secretariapublica@saocamilo-sp.brhttps://doi.org/10.15343/0104-78091980-39900104-7809opendoar:2020-08-14T18:53:03O Mundo da Saúde (Online) - Centro Universitário São Camilofalse
score 15.301629

Similares en LA Referencia